Lv32
314 积分 2024-08-02 加入
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
53分钟前
已关闭
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
1小时前
已完结
Cancer burden and control in China: landscape, trends and challenges
1小时前
已完结
Systemic Therapy for Metastatic Renal Cell Carcinoma
2小时前
已完结
Diagnostic liquid biopsy biomarkers in renal cell cancer
8天前
已完结
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial
11天前
已完结
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
11天前
已完结
Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma
12天前
已完结
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
12天前
已完结
Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management
12天前
已完结
皖公网安备34019202002308
